Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-α and IFN-γ1

Journal of Immunology

Volumn 161, Issue 12, 1998, Pages 6664-6673

  Qin, Hongwei ^a   Moellinger, Jason D ^b   Wells, Alan ^b   Windsor, L Jack ^c   Sun, Yi ^d   Benveniste, Etty N ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GELATINASE A; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASTROCYTOMA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ASTROCYTES; ASTROCYTOMA; BRAIN NEOPLASMS; COLLAGENASES; CYTOKINES; ENZYME INDUCTION; FRONTAL LOBE; GELATINASES; HUMANS; INTERFERON-GAMMA, RECOMBINANT; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; RECOMBINANT PROTEINS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032534568     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Birkedal-Hansen, H. 1995. Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol. 7:728.
2. Stetler-Stevenson, W. G., R. Hewitt, and M. Corcoran. 1996. Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Cancer Biol. 7:147.
3. Chambers, A. F., and L. M. Matrisian. 1997. Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89:1260.
4. Coussens, L. M., and Z. Werb. 1996. Matrix metalloproteinases and the development of cancer. Chem. Biol. 3:895.
5. Yu, A. E., R. E. Hewitt, D. E. Kleiner, and W. G. Stetler-Stevenson. 1996. Molecular regulation of cellular invasion-role of gelatinase A and TIMP-2. Biochem. Cell Biol. 74:823.
6. Takino, T., H. Sato, A. Shinagawa, and M. Seiki. 1995. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. J. Biol. Chem. 270:23013.
7. Strongin, A. Y., I. Collier, G. Bannikov, B. L. Marmer, G. A. Grant, and G. I. Goldberg. 1995. Mechanism of cell surface activation of 72-kDa type IV collagenase: isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270:5331.
8. Lee, A. Y., K. T. Akers, M. Collier, L. Li, A. Z. Eisen, and J. L. Seltzer. 1997. Intracellular activation of gelatinase A (72-kDa type IV collagenase) by normal fibroblasts. Proc. Natl. Acad. Sci. USA 94:4424.
9. Taylor, K. B., L. J. Windsor, N. C. M. Caterina, M. K. Bodden, and J. A. Engler. 1996. The mechanism of inhibition of collagenase by TIMP-1. J. Biol. Chem. 271:23938.
10. Gomis-Rüth, F.-X., K. Maskos, M. Setz, A. Bergner, R. Huber, K. Suzuki, N. Yoshida, H. Nagase, K. Brew, G. P. Bourenkov, H. Bartunik, and W. Bode. 1997. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 389:77.
11. Gomez, D. E., D. F. Alonso, H. Yoshiji, and U. P. Thorgeirsson. 1997. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 74:111.
12. Himelstein, B. P., R. Canete-Soler, E. J. Bernhard, D. W. Dilks, and R. J. Muschel. 1995. Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metastasis 14:246.
13. Barillé, S., C. Akhoundi, M. Collette, M.-P. Mellerin, M.-J. Rapp, J.-L. Harousseau, R. Bataille, and M. Aminot. 1997. Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells. Blood 90:1649.
14. Sato, H., Y. Kida, M. Mai, Y. Endo, T. Sasaki, J. Tanaka, and M. Seiki. 1992. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 7:77.
15. Uhm, J. H., N. P. Dooley, J.-G. Villemure, and V. W. Yong. 1997. Mechanisms of glioma invasion: role of matrix-metalloproteinases. Can. J. Neurol. Sci. 24:3.
16. Yong, V. W., C. A. Krekoski, P. A. Forsyth, R. Bell, and D. R. Edwards. 1998. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 21:75.
17. Abe, T., T. Mori, K. Kohno, M. Seiki, T. Hayakawa, H. G. Welgus, S. Hori, and M. Kuwano. 1994. Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells, Clin. Exp. Metastasis 12:296.
18. Apodaca, G., J. T. Rutka, K. Bouhana, M. E. Berens, J. R. Giblin, M. L. Rosenblum, J. H. Mckerrow, and M. J. Banda. 1990. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res. 50:2322.
19. Nakano, A., E. Tani, K. Miyazaki, Y. Yamamoto, and J.-I. Furuyama. 1995. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J. Neurosurg. 83:298.
20. Yamamoto, M., S. Mohanam, R. Sawaya, G. N. Fuller, M. Seiki, H. Sato, Z. L. Gokaslan, L. A. Liotta, G. L. Nicolson, and J. S. Rao. 1996. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res. 56:384.
21. Rao, J. S., P. A. Steck, P. Toulon, D. Boyd, F. Ali-Osman, W. G. Stetler-Stevenson, L. A. Liotta, and R. Sawaya. 1994. Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model. J. Neuroonc. 18:129.
22. 1 integrin. Cancer Lett. 103:201.
23. Uhm, J. H., N. P. Dooley, J.-G. Villemure, and V. W. Yong. 1996. Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C. Clin. Exp. Metastasis 14:421.
24. Nakagawa, T., T. Kubota, M. Kabuto, K. Sato, H. Kawano, T. Hayakawa, and Y. Okada. 1994. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J. Neurosurg. 81:69.
25. Mohanam, S., S. W. Wang, A. Rayford, M. Yamamoto, R. Sawaya, M. Nakajima, L. A. Liotta, G. L. Nicolson, W. G. Stetler-Stevenson, and J. S. Rao. 1995. Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo. Clin. Exp. Metastasis 13:57.
26. 1 92,000 type IV collagenase in human brain tumors. Cancer Res. 53:2208.
27. Sawaya, R. E., M. Yamamoto, Z. L. Gokaslan, S. W. Wang, S. Mohanam, G. N. Fuller, I. E. McCutcheon, W. G. Stetler-Stevenson, G. L. Nicolson, and J. S. Rao. 1996. Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin. Exp. Metastasis 14:35.
28. Rao, J. S., M. Yamamoto, S. Mohaman, Z. L. Gokaslan, G. N. Fuller, W. G. Stetler-Stevenson, V. H. Rao, L. A. Liotta, G. L. Nicolson, and R. E. Sawaya. 1996. Expression and localization of 92 kDa type IV collagenase/ gelatinase B (MMP-9) in human gliomas. Clin. Exp. Metastasis 14:12.
29. Mauviel, A. 1993. Cytokine regulation of metalloproteinase gene expression. J. Cell. Biochem. 53:288.
30. Ries, C., and P. E. Petrides. 1995. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol. Chem. Hoppe-Seyler 376:345.
31. Overall, C. M., J. L. Wrana, and J. Sodek. 1991. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-β1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J. Biol. Chem. 266:14064.
32. Mertens, P. R., S. Harendza, A. S. Pollock, and D. H. Lovett. 1997. Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1. J. Biol. Chem. 272:22905.
33. Harendza, S., A. S. Pollock, P. R. Mertens, and D. H. Lovett. 1995. Tissue-specific enhancer-promoter interactions regulate high levels constitutive expression of matrix metalloproteinase 2 by glomerular mesangial cells. J. Biol. Chem. 270:18786.
34. Bian, J., and Y. Sun. 1997. Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol. Cell. Biol. 17:6330.
35. 2 stimulates expression of matrix metalloproteinase 2 in cultured rat mesangial cells. Kidney Int. 51:1116.
36. Leppert, D., S. L. Hauser, J. L. Kishiyama, S. An, L. Zeng, and E. J. Goetzl. 1995. Stimulation of matrix metalloproteinase-dependent migration of T cells by eicosanoids. FASEB J. 9:1473.
37. Wahl, S. M., J. B. Allen, B. S. Weeks, H. L. Wong, and P. E. Klotman. 1993. Transforming growth factor β enhances integrin expression and type IV collagenase secretion in human monocytes. Proc. Natl. Acad. Sci. USA 90:4577.
38. Xie, B., Z. Dong, and I. J. Fidler. 1994. Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages. J. Immunol. 152:3637.
39. Salo, T., J. G. Lyons, F. Rahemtulla, H. Birkedal-Hansen, and H. Larjava. 1991. Transforming growth factor-β1 up-regulates type IV collagenase expression in cultured human keratinocytes. J. Biol. Chem. 266:11436.
40. Mackay, A. R., M. Ballin, M. D. Pelina, A. R. Farina, A. M. Nason, J. L. Hartzler, and U. P. Thorgeirsson. 1992. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis 12:168.
41. Wu, A. J., R. M. Lafrenie, C. Park, W. Apinhasmit, Z. J. Chen, H. Birkedal-Hansen, K. M. Yamada, W. G. Stetler-Stevenson, and B. J. Baum. 1997. Modulation of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) by interferon-γ in a human salivary gland cell line. J. Cell. Physiol. 171:117.
42. Marti, H.-P., L. McNeil, M. Davies, J. Martin, and D. H. Lovett. 1993. Homology cloning of rat 72 kDa type IV collagenase: cytokine and second-messenger inducibility in glomerular mesangial cells. Biochem. J. 291:441.
43. Marti, H. P., L. Lee, M. Kashgarian, and D. H. Lovett. 1994. Transforming growth factor-β1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase. Am. J. Pathol. 144:82.
44. Lee, Y.-J., Y. Han, H.-T. Lu, V. Nguyen, H. Qin, P. H. Howe, B. A. Hocevar, J. M. Boss, R. M. Ransohoff, and E. N. Benveniste. 1997. TGF-β suppresses IFN-γ induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. J. Immunol. 158:2065.
45. Winkler, M., and E. N. Benveniste. 1998. Transforming growth factor-β inhibition of cytokine-induced vascular cell adhesion molecule-1 expression in human astrocytes. GLIA 22:171.
46. Lee, Y.-J., and E. N. Benveniste. 1996. STAT-1α expression is involved in IFN-γ induction of the class II transactivator and class II MHC genes. J. Immunol. 157:1559.
47. Overall, C. M., J. L. Wrana, and J. Sodek. 1989. Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-β. J. Biol. Chem. 264:1860.
48. Panek, P. B., Y.-J. Lee and E. N. Benveniste. 1995. TGF-β suppression of IFN-γ induced class II MHC gene expression does not involve inhibition of phosphorylation of JAK1, JAK2 or STAT1α or modification of IFNEX expression. J. Immunol. 154:610.
49. Strongin, A. Y., B. L. Marmer, G. A. Grant, and G. I. Goldberg. 1993. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J. Biol. Chem. 268:14033.
50. Shrikant, P., S. J. Lee, I. Kalvakalanu, R. M. Ransohoff, and E. N. Benveniste. 1996. Stimulus-specific inhibition of ICAM-1 gene expression by TGF-β. J. Immunol. 157:892.
51. Xie, H., T. Turner, M.-H. Wang, R. K. Singh, G. P. Siegal, and A. Wells. 1995. In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals. Clin. Exp. Metastasis 13:407.
52. Bethea, J. R., G. Y. Gillespie, and E. N. Benveniste. 1992. Interleukin-1β induction of TNF-α gene expression: involvement of protein kinase C. J. Cell. Physiol. 152:264.
53. Bethea, J. R., I. Y. Chung, S. M. Sparacio, G. Y. Gillespie, and E. N. Benveniste. 1992. Interleukin-1β induction of tumor necrosis factor-α gene expression in human astroglioma cells. J. Neuroimmunol. 36:179.
54. Ballestas, M. E., and E. N. Benveniste. 1997. Elevation of cyclic AMP levels in astrocytes antagonizes cytokine-induced adhesion molecule expression. J. Neurochem. 69:1438.
55. Gottschall, P. E., and X. Yu. 1995. Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J. Neurochem. 64: 1513.
56. Rosenman, S. J., P. Shrikant, L. Dubb, E. N. Benveniste, and R. M. Ransohoff. 1995. Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines. J. Immunol. 154:1888.
57. Itoh, T., M. Tanioka, H. Yoshida, T. Yoshioka, H. Nishimoto, and S. Itohara. 1998. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58:1048.
58. Gohji, K., I. J. Fidler, R. Tsan, R. Radinsky, A. C. von Eschenbach, T. Tsuruo, and M. Nakajima. 1994. Human recombinant interferons-β and -γ decrease gelatinase production and invasion by human KG-2 renalcarcinoma cells. Int. J. Cancer 58:380.
59. r 92,000 type-IV collagenase (gelatinase A and B) gene expression by interferons α and γ in human melanoma. Int. J. Cancer 58:582.
60. Bethea, J. R., G. Y. Gillespie, I. Y. Chung, and E. N. Benveniste. 1990. Tumor necrosis factor production and receptor expression by a human astroglioma cell line. J. Neuroimmunol. 30:1.
61. Frisch, S. M., and J. H. Morisaki. 1990. Positive and negative transcriptional elements of the human type IV collagenase gene. Mol. Cell. Biol. 10:6524.
62. Tada, M., and N. de Tribolet. 1997. Immunobiology of malignant gliomas. In Advances in Neuro-oncology II. P. L. Kornblith and M. D. Walker, eds. Futura Publishing Co., Armonk, NY, pp. 447.
63. Adachi, K., P. Belser, H. Bender, D. Li, U. Rodeck, E. N. Benveniste, D. Woo, W. H. Schmiegel, and D. Herlyn. 1992. Enhancement of epidermal growth factor receptor expression on glioma cells by recombinant tumor necrosis factor α. Cancer Immunol. Immunother. 34:370.